Dublin, April 03, 2025 (GLOBE NEWSWIRE) — The “Protein Engineering – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Protein Engineering was valued at US$3.5 Billion in 2024 and is projected to reach US$7.8 Billion by 2030, growing at a CAGR of 14.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Protein engineering is revolutionizing biopharmaceuticals by enabling the development of tailored therapeutic proteins with enhanced effectiveness, stability, and target specificity. By manipulating protein structures, scientists can create monoclonal antibodies, enzymes, and other therapeutic proteins with optimized properties for treating specific diseases.
The Growth in the Protein Engineering Market Is Driven by Several Factors.
The growth in the protein engineering market is driven by several factors, including advances in technology, expanding end-use applications, and evolving consumer demands. Technological innovations such as CRISPR gene editing, high-throughput screening, and AI-powered predictive modeling are making it easier to design proteins with specific functions, opening new avenues in drug discovery, diagnostics, and industrial applications.
End-use industries like pharmaceuticals, agriculture, food and beverage, and environmental science are increasingly adopting engineered proteins, as they offer tailored solutions for disease treatment, sustainable production, and environmental cleanup. For example, the growing demand for biologics in the pharmaceutical industry is driving the need for engineered proteins that can target diseases more effectively and with fewer side effects, particularly in fields like oncology and immunology. Additionally, consumer interest in sustainable and eco-friendly products is encouraging the development of bioengineered proteins for use in everyday products, from biodegradable packaging to plant-based food alternatives.
In environmental science, proteins engineered to degrade pollutants or capture greenhouse gases are finding applications in climate change mitigation efforts. Furthermore, the rise of personalized medicine and the push for precision diagnostics are accelerating the use of engineered proteins in patient-specific therapies and diagnostics, further expanding the market’s potential. These converging trends underscore the transformative role of protein engineering in addressing both global challenges and consumer expectations, fueling its growth across multiple sectors.
What Role Does Synthetic Biology Play in Protein Engineering Innovation?
Synthetic biology has become a powerful tool within protein engineering, allowing researchers to design proteins with novel functionalities that meet specific industrial, environmental, and medical needs. Advances in gene-editing technologies like CRISPR and TALEN have made it easier to modify protein structures precisely, creating new capabilities and expanding protein engineering’s applications. Synthetic biology has also propelled the development of sustainable enzymes used in industrial processes, replacing harsh chemicals with environmentally friendly biocatalysts. For instance, engineered enzymes are now widely used in the textile, detergent, and biofuel industries, where they help reduce energy consumption, lower waste production, and improve efficiency.
Moreover, by incorporating computational models and high-throughput screening, synthetic biology enables scientists to create proteins that exhibit enhanced stability and functionality under challenging conditions, such as extreme temperatures or pH levels. These engineered proteins are also proving valuable in environmental cleanup, where proteins designed to degrade pollutants or capture carbon dioxide are being deployed to mitigate environmental damage. The synergy between synthetic biology and protein engineering is expanding the possibilities for innovation, allowing proteins to be designed for virtually any application imaginable, making them indispensable across industries.
How Are AI and Machine Learning Transforming Protein Engineering?
AI and machine learning are transforming protein engineering by significantly speeding up the design and optimization processes. Traditionally, protein engineering was a time-intensive field, requiring countless iterations to achieve desired protein properties. However, the introduction of AI algorithms has dramatically reduced this complexity by using data-driven predictions to model protein behavior, enabling researchers to foresee structural interactions and modifications with remarkable accuracy. Machine learning algorithms trained on protein data have made it possible to predict protein folding, stability, and function, thus reducing experimental trial and error. Companies and research institutions are now able to utilize AI-driven design tools for virtual screening, optimizing protein structures before they are ever physically tested.
This has proved invaluable in drug discovery, where AI helps identify protein targets quickly, accelerating the development of therapeutics. Additionally, machine learning is facilitating the use of directed evolution, a process that mimics natural selection to evolve proteins with specific characteristics. This technique, when combined with AI-based predictive modeling, allows scientists to enhance proteins’ efficiency and stability exponentially. The integration of AI and machine learning in protein engineering not only improves the accuracy of protein modifications but also enables the rapid development of novel proteins, revolutionizing the approach to scientific discovery in this field.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Protein Engineering Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Protein Engineering Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abzena, Ltd., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Codexis, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Segments
- Product (Instruments, Reagents, Software & Services)
- Technology (Rational Protein Design, Directed Evolution, Hybrid Approach)
- End-Use (Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutes)
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 81 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $3.5 Billion |
| Forecasted Market Value (USD) by 2030 | $7.8 Billion |
| Compound Annual Growth Rate | 14.5% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Protein Engineering – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
MARKET TRENDS & DRIVERS
- Rising Demand for Therapeutic Proteins in Biopharmaceuticals Drives Growth in Protein Engineering Solutions
- Increased Focus on Precision Medicine Spurs Development of Customized and Targeted Protein Therapies
- Advances in CRISPR and Gene Editing Technologies Expand Capabilities in Protein Engineering for Disease Treatment
- Growth of Monoclonal Antibodies and Enzyme Replacement Therapies Elevates Market for Engineered Proteins
- Increased Use of Protein Engineering in Vaccine Development Supports Market, Especially for Viral Disease Prevention
- Rising Investment in Synthetic Biology Enhances Market for Engineered Proteins with Novel Functionalities
- Expansion of Structural Biology and Computational Modeling Improves Accuracy and Efficiency in Protein Design
- High Demand for Sustainable Industrial Enzymes Spurs Development of Engineered Proteins for Industrial Applications
- Increased Focus on Biocatalysis in Pharmaceutical Manufacturing Drives Use of Custom Enzymes and Proteins
- Growth in Agricultural Biotechnology Fuels Demand for Engineered Proteins in Crop Protection and Yield Enhancement
- Advances in AI and Machine Learning Enhance Predictive Modeling for Protein Function and Stability
- Rising Demand for Protein-Based Biosensors and Diagnostic Tools Expands Applications in Clinical and Environmental Testing
FOCUS ON SELECT PLAYERS
- Abzena, Ltd.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Codexis, Inc.
- Creative Biolabs
- Danaher Corporation
- Enantis S.R.O.
- GE Healthcare
- Genscript Biotech Corporation
- Innovagen AB
- Merck KGaA
- New England Biolabs, Inc.
- Perkinelmer, Inc.
- Phynexus, Inc. (A Part of Biotage)
- Promega Corporation
- Proteogenix
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
- Waters Corporation
For more information about this report visit https://www.researchandmarkets.com/r/31h7m1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Protein Engineering Market
